EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validation

Ki Hong Kim, Dae Young Lee, Hee Jo Yang, Si Hyun Kim, Doo Sang Kim, Chang Ho Lee, Soon Auck Hong, Byung Hoon Chi, Ji-Hye Lee, Youn Soo Jeon

Cancer Treatment and Research Communications · 2026 · 48 · 101278

DOI: 10.1016/j.ctarc.2026.101278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Ki Hong Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, South Korea. Hauptthemen laut MEDLINE: Seminoma, Testicular Neoplasms, Hepatitis A Virus Cellular Receptor 2, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Soonchunhyang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeminomaTesticular NeoplasmsHepatitis A Virus Cellular Receptor 2Biomarkers, TumorHumansMalePrognosisAdultMiddle Aged

Stichwörter der Autor:innen

HAVCR2Immune checkpointPrognosisSeminomaTIM-3Testicular germ cell tumorTumor microenvironment

Substanzen

Hepatitis A Virus Cellular Receptor 2Biomarkers, TumorHAVCR2 protein, human

Autor:innen und Institutionen

  • Department of Urology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, South Korea.
  • Department of Pathology, College of Medicine, Chung-Ang University, Seoul, South Korea.
  • Department of Urology, Gimpo Woori Hospital, Gimpo, South Korea.
  • Department of Pathology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, South Korea. Electronic address: whui01@schmc.ac.kr.
  • Department of Urology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, South Korea. Electronic address: ysurol@schmc.ac.kr.

Förderung

  • Soonchunhyang University

Zitieren

APA

Kim, K. H., Lee, D. Y., Yang, H. J., Kim, S. H., Kim, D. S., Lee, C. H., Hong, S. A., Chi, B. H., Lee, J. H., & Jeon, Y. S. (2026). HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validation. Cancer Treatment and Research Communications, 48, 101278. https://doi.org/10.1016/j.ctarc.2026.101278

Vancouver

Kim KH, Lee DY, Yang HJ, Kim SH, Kim DS, Lee CH, et al. HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validation. Cancer Treatment and Research Communications. 2026;48:101278. doi:10.1016/j.ctarc.2026.101278

BibTeX
@article{Kim2026,
  author = {Kim, Ki Hong and Lee, Dae Young and Yang, Hee Jo and Kim, Si Hyun and Kim, Doo Sang and Lee, Chang Ho and Hong, Soon Auck and Chi, Byung Hoon and Lee, Ji-Hye and Jeon, Youn Soo},
  title = {HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validation},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {48},
  pages = {101278},
  doi = {10.1016/j.ctarc.2026.101278}
}
Kostenlos starten →